A phase I trial and pharmacokinetic study of tipifarnib, a farnesyltransferase inhibitor, and tamoxifen in metastatic breast cancer. [electronic resource]
Producer: 20050531Description: 1247-52 p. digitalISSN:- 1078-0432
- Adult
- Aged
- Alkyl and Aryl Transferases -- antagonists & inhibitors
- Anemia -- chemically induced
- Antineoplastic Agents, Hormonal -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Area Under Curve
- Breast Neoplasms -- drug therapy
- Dose-Response Relationship, Drug
- Exanthema -- chemically induced
- Farnesyltranstransferase
- Fatigue -- chemically induced
- Female
- Humans
- Leukocytes, Mononuclear -- drug effects
- Male
- Middle Aged
- Neoplasm Metastasis
- Quinolones -- administration & dosage
- Tamoxifen -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.